It is also worth noting that despite the earlier observation of in vitro activation of the AR by growth factors, including members of the FGF family (Culig et al, 1994), whether aberrant FGFR signalling may contribute to prostate carcinogenesis via ligand-independent activation of AR remains unclear. The gene discussed is AR; the disease is urogenital neoplasm.